单位：[1]Real-World Insights, IQVIA, Beijing, China[2]Medical Affairs, AstraZeneca, Beijing, China[3]National Clinical Research Center for Respiratory Diseases Institute of Respiratory Medicine Chinese Academy of Medical Science Department of Pulmonary and Critical Care Medicine, China-Japan Friendship Hospital, Beijing, China[4]Department of Respiratory and Critical Care Medicine, The First Affiliated Hospital of Nanjing Medical University, Nanjing, China江苏省人民医院[5]Department of Health Economics, School of International Pharmaceutical Business, China Pharmaceutical University, Nanjing, China[6]National Center for Chronic and Non-Communicable Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing, China[7]National Clinical Research Center for Respiratory Disease, The First Affiliated Hospital of Guangzhou Medical University, Guangzhou, China
We built a decision-analytic model to compare the cost-effectiveness of using portable spirometer and questionnaire to screen chronic obstructive pulmonary diseases (COPD) with no screening (i.e. usual care) among chronic bronchitis patient in China. A lifetime horizon and a payer perspective were adopted. Cost data of health services including spirometry screening and treatment costs covered both maintenance and exacerbation. The result indicated that portable spirometer screening was cost-saving compared with questionnaire screening and no screening, with an incremental cost-effectiveness ratio (ICER) of -5026 and -1766 per QALY, respectively. Sensitivity analyses confirmed the robustness of the results. In summary, portable spirometer screening is likely the optimal option for COPD screening among chronic bronchitis patients China.
第一作者单位：[1]Real-World Insights, IQVIA, Beijing, China
通讯作者：
推荐引用方式(GB/T 7714)：
Qu Shuli,You Xuedan,Liu Tianyi,et al.Cost-effectiveness analysis of COPD screening programs in primary care for high-risk patients in China[J].NPJ PRIMARY CARE RESPIRATORY MEDICINE.2021,31(1):doi:10.1038/s41533-021-00233-z.
APA：
Qu, Shuli,You, Xuedan,Liu, Tianyi,Wang, Lijiao,Yin, Zheng...&Zheng, Jinping.(2021).Cost-effectiveness analysis of COPD screening programs in primary care for high-risk patients in China.NPJ PRIMARY CARE RESPIRATORY MEDICINE,31,(1)
MLA：
Qu, Shuli,et al."Cost-effectiveness analysis of COPD screening programs in primary care for high-risk patients in China".NPJ PRIMARY CARE RESPIRATORY MEDICINE 31..1(2021)
